Clinical Trial Update: Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexamethasone plus virtual reality exposure therapy for post-traumatic stress disorder completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Emory University | Conditions: PTSD | Phase 4 | Status: COMPLETED | Results posted: 2018-07-12